APA (7th ed.) Citation

C, J., LS, S., F, X., N, N., HL, G., JW, D., . . . BC, J. (2020). HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer. Frontiers in oncology, 10, 603480. https://doi.org/10.3389/fonc.2020.603480

Chicago Style (17th ed.) Citation

C, Ji, Sun LS, Xing F, Niu N, Gao HL, Dai JW, Zhou N, and Jiang BC. "HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer." Frontiers in Oncology 10 (2020): 603480. https://doi.org/10.3389/fonc.2020.603480.

MLA (9th ed.) Citation

C, Ji, et al. "HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer." Frontiers in Oncology, vol. 10, 2020, p. 603480, https://doi.org/10.3389/fonc.2020.603480.